The virus does not enter human cells as readily as SARS-CoV-2 does, the Chinese researchers reported in the journal Cell, ...

Researchers have discovered a virus that could enter human cells in a similar way to COVID-19. But they caution it's much ...

We can refer to full-year 2019 revenue of about $51 billion and the company's comments about potential revenue of more than ...

An archived Facebook post claimed that Pfizer has released a list of side effects for COVID vaccine. The claim by the user is ...

Pfizer may appeal to income investors, but growth prospects remain uncertain. Read why PFE stock might struggle to gain ...

Paxlovid may not decrease the risk for hospitalization or death in older adults vaccinated against COVID-19 as much as ...

An epidemiologist said the Franklin County resolution was "based on conspiracy and misinformation against the COVID-19 ...

Claims on social media suggest Pfizer's COVID vaccine has fatal side effects, referencing a US House document. However, the ...

Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to new UCLA-led research.

PFE offers a 6.73% dividend yield and growth potential, driven by strategic acquisitions, R&D, and discounted valuations.

Yale scientists have discovered a syndrome linked to the COVID vaccines & Chinese researchers have discovered a new bat coronavirus.

All this negativity, however, does open up an opportunity for investors to buy the stock at a discount. Despite being a top ...